Is 0.15 mmol/kg of contrast agent effective for delayed-enhancement magnetic resonance imaging at 1.5 T?
Yuhuangding Hospital, Yantai, Shandong Province, China.
Heng
H
Ma
Yuhuangding Hospital, Yantai, Shandong Province, China. Electronic address: yangjunyhd@163.com.
Jun
J
Yang
RuiJin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China.
Yong
Y
Wang
Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zhaoying
Z
Wen
Xijing Hospital, Fourth Military Medical University, China.
Ying
Y
Liu
Yuhuangding Hospital, Yantai, Shandong Province, China.
Jing
J
Liu
Shandong Province Characteristical Key Subject "Medical Imaging and Nuclear Medicine" Based on Binzhou Medical University, Yantai, Shandong Province, China. Electronic address: binwang001@aliyun.com.
Bin
B
Wang
D003911:Dextrans / Q000008:administration & dosage* / Q000009:adverse effects*; D005260:Female; D006801:Humans; D019028:Magnetic Resonance Imaging, Cine; D058185:Magnetite Nanoparticles / Q000008:administration & dosage* / Q000009:adverse effects*; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D020257:Ventricular Remodeling / Q000187:drug effects*
D003911:Dextrans; D058185:Magnetite Nanoparticles
Cardiac magnetic resonance imaging; Contrast dose; Late enhancement